Finland· FI-REL-REL3439
Norprolac
A quinagolide product containing quinagolide hydrochloride, registered in Finland by Novartis Finland Oy. The same ATC class is registered in 9 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Quinagolide is registered in 9 of 19 countries.
Countries holding a registration under ATC G02CB04 (quinagolide), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 6 of them publish a price we can compare per daily dose
Quinagolide · ATC G02CB04
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
Fimea (Finland)- Active substance
- Quinagolide hydrochloride
- Manufacturer
- Novartis Finland Oy
- Country
- Finland (FI)
- ATC code
- G02CB04
- ATC class
- Quinagolide
- Defined daily dose
- 75 mcg, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Quinagolide in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandNorprolac 150 ug, TablettenFerring AG
- SwedenNorprolac 150 mikrogram TablettFerring Läkemedel AB
- United KingdomNorprolac 25microgram tabletsFerring Pharmaceuticals Ltd
- BelgiumNorprolac 150 µgFerring
- FranceNORPROLAC 150 microgrammes, compriméFERRING (FRANCE)
- SpainNORPROLAC 25 MICROGRAMOS Y 50 MICROGRAMOS COMPRIMIDOSFerring S.A.
- PolandNorprolacFerring GmbH
- CzechiaNORPROLACFerring-Léčiva, a.s., Jesenice u Prahy
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Austria · Norprolac
- Czechia · Norprolac
- Germany · Norprolac
- France · Norprolac
- United Kingdom (Northern Ireland) · Norprolac, Quinagolide Aspire Pharma
- Greece · Norprolac
- Hungary · Norprolac
- Netherlands · Norprolac
- Poland · Norprolac
- Slovakia · Norprolac
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/db56f408-e855-41e1-bb84-1bf5a8ac3e99 GET /v1/drugs/db56f408-e855-41e1-bb84-1bf5a8ac3e99?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "75",
"form": "tabletti",
"route": null,
"ddd_unit": "mcg",
"strength": "150 mikrog",
"atc_label": "kinagolidi",
"ma_number": "11398",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL3439",
"authorised_at": "1994-03-07"
}See everything about quinagolide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.